BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34755313)

  • 21. Alternative clinical end points in rectal cancer--are we getting closer?
    Glynne-Jones R; Mawdsley S; Pearce T; Buyse M
    Ann Oncol; 2006 Aug; 17(8):1239-48. PubMed ID: 16873440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disparities in Clinical Trial Enrollment and Reporting in Rectal Cancer: A Systematic Review and Demographic Comparison to the National Cancer Database.
    Sawaf T; Gudipudi R; Ofshteyn A; Sarode AL; Bingmer K; Bliggenstorfer J; Stein SL; Steinhagen E;
    Am Surg; 2024 Jan; 90(1):130-139. PubMed ID: 37670471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.
    Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB
    Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reevaluation of Preoperative Chemoradiotherapy for Clinical T3 Lower Rectal Cancer: A Multicenter Collaborative Retrospective Clinical Study.
    Takeda M; Kawahara H; Ogawa M; Suwa K; Eto K; Yanaga K
    Anticancer Res; 2019 Jun; 39(6):3047-3052. PubMed ID: 31177147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of preoperative transcatheter rectal arterial chemoembolization with concurrent chemoradiotherapy on surgery and prognosis of patients with locally advanced rectal cancer.
    Meng W; Yang B; Huang B; Chen C; Zhu J; Jian D; Zhong L; Wang D; Li C; Bai L
    J Surg Oncol; 2021 Dec; 124(8):1451-1458. PubMed ID: 34510454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma.
    Wong RK; Tandan V; De Silva S; Figueredo A
    Cochrane Database Syst Rev; 2007 Apr; (2):CD002102. PubMed ID: 17443515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical, oncological, and functional outcomes of local and radical resection after neoadjuvant chemotherapy or chemoradiotherapy for early- and mid-stage rectal cancer: a systematic review and meta-analysis.
    Tan S; Ou Y; Huang S; Gao Q
    Int J Colorectal Dis; 2023 May; 38(1):132. PubMed ID: 37193915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.
    Bahadoer RR; Dijkstra EA; van Etten B; Marijnen CAM; Putter H; Kranenbarg EM; Roodvoets AGH; Nagtegaal ID; Beets-Tan RGH; Blomqvist LK; Fokstuen T; Ten Tije AJ; Capdevila J; Hendriks MP; Edhemovic I; Cervantes A; Nilsson PJ; Glimelius B; van de Velde CJH; Hospers GAP;
    Lancet Oncol; 2021 Jan; 22(1):29-42. PubMed ID: 33301740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 30. Extended-field radiotherapy for locally advanced cervical cancer.
    Thamronganantasakul K; Supakalin N; Kietpeerakool C; Pattanittum P; Lumbiganon P
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012301. PubMed ID: 30362204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative radiotherapy and curative surgery for the management of localised rectal carcinoma.
    Abraha I; Aristei C; Palumbo I; Lupattelli M; Trastulli S; Cirocchi R; De Florio R; Valentini V
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD002102. PubMed ID: 30284239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis of oxaliplatin-based versus fluorouracil-based neoadjuvant chemoradiotherapy and adjuvant chemotherapy for locally advanced rectal cancer.
    Fu XL; Fang Z; Shu LH; Tao GQ; Wang JQ; Rui ZL; Zhang YJ; Tian ZQ
    Oncotarget; 2017 May; 8(21):34340-34351. PubMed ID: 28423720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant chemotherapy for advanced endometrial cancer.
    Galaal K; Al Moundhri M; Bryant A; Lopes AD; Lawrie TA
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD010681. PubMed ID: 24832785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical timing after chemoradiotherapy for rectal cancer, analysis of technique (STARRCAT): results of a feasibility multi-centre randomized controlled trial.
    Foster JD; Ewings P; Falk S; Cooper EJ; Roach H; West NP; Williams-Yesson BA; Hanna GB; Francis NK;
    Tech Coloproctol; 2016 Oct; 20(10):683-93. PubMed ID: 27510524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Application of endoscopic tattooing with carbon nanoparticlet in the treatment for advanced colorectal cancer].
    Wang R; Zhan HL; Li DZ; Li HT; Yu L; Wang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jan; 23(1):56-64. PubMed ID: 31958932
    [No Abstract]   [Full Text] [Related]  

  • 36. Intensity-Modulated Radiation Therapy Is Not Associated with Perioperative or Survival Benefit over 3D-Conformal Radiotherapy for Rectal Cancer.
    Sun Z; Adam MA; Kim J; Czito B; Mantyh C; Migaly J
    J Gastrointest Surg; 2017 Jan; 21(1):106-111. PubMed ID: 27510332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer After Preoperative Chemoradiotherapy (ADORE): Long-Term Results of a Randomized Controlled Trial.
    Hong YS; Kim SY; Lee JS; Nam BH; Kim KP; Kim JE; Park YS; Park JO; Baek JY; Kim TY; Lee KW; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
    J Clin Oncol; 2019 Nov; 37(33):3111-3123. PubMed ID: 31593484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and short-term outcomes of preoperative chemoradiotherapy with intermittent oral tegafur-uracil plus leucovorin in Japanese rectal cancer patients: a single center experience retrospective analysis.
    Nakagawa R; Inoue Y; Ohki T; Kaneko Y; Maeda F; Yamamoto M
    World J Surg Oncol; 2017 May; 15(1):112. PubMed ID: 28566093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delaying surgery after neoadjuvant chemoradiotherapy in rectal cancer has no influence in surgical approach or short-term clinical outcomes.
    Figueiredo N; Panteleimonitis S; Popeskou S; Cunha JF; Qureshi T; Beets GL; Heald RJ; Parvaiz A
    Eur J Surg Oncol; 2018 Apr; 44(4):484-489. PubMed ID: 29398323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials.
    Hartley A; Ho KF; McConkey C; Geh JI
    Br J Radiol; 2005 Oct; 78(934):934-8. PubMed ID: 16177017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.